Inhibition of HSP90β Improves Lipid Disorders by Promoting Mature SREBPs Degradation via the Ubiquitin-proteasome System

Zu‐Guo Zheng(China Pharmaceutical University), Xiaojun Xu(The Fourth People's Hospital), Xiao-Xiao Liu(Chinese Academy of Sciences), Xiuxiu Jin(Sichuan University), Weiliang Zhu(Nanjing University of Chinese Medicine), Pyone Myat Thu(China Pharmaceutical University), Lunzhi Dai(Sichuan University), Xin Zhang(Academy of Military Medical Sciences), Yu Li(China Medical University), Hui‐Jun Li(China Pharmaceutical University), Cheng Peng(Chinese Academy of Sciences), Chang Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Lin Wang(Zhuzhou Central Hospital), Ping Li(First Hospital of Lanzhou University), Hongyang Li(Inner Mongolia Agricultural University), Junli Liu(Shanghai Jiao Tong University), Mu Zhang(Liaoning University of Traditional Chinese Medicine), Huimin Cheng(China Pharmaceutical University), Ligong Chen(Diagnostics for the Real World (United States)), Dan Jing(China Pharmaceutical University), Jing Zhu(Hangzhou First People's Hospital), Bin Xue(China Pharmaceutical University)
Theranostics
January 1, 2019
Cited by 82


Related Papers